BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21299246)

  • 1. Gallic acid induces G2/M phase arrest of breast cancer cell MCF-7 through stabilization of p27(Kip1) attributed to disruption of p27(Kip1)/Skp2 complex.
    Hsu JD; Kao SH; Ou TT; Chen YJ; Li YJ; Wang CJ
    J Agric Food Chem; 2011 Mar; 59(5):1996-2003. PubMed ID: 21299246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physalis angulata induced G2/M phase arrest in human breast cancer cells.
    Hsieh WT; Huang KY; Lin HY; Chung JG
    Food Chem Toxicol; 2006 Jul; 44(7):974-83. PubMed ID: 16427178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
    Auld CA; Fernandes KM; Morrison RF
    J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of Cdk inhibitors through both sequestration and downregulation in zearalenone-treated MCF-7 breast cancer cells.
    Ahamed S; Foster JS; Bukovsky A; Diehl JA; Wimalasena J
    Mol Carcinog; 2002 May; 34(1):45-58. PubMed ID: 12112322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daidzein causes cell cycle arrest at the G1 and G2/M phases in human breast cancer MCF-7 and MDA-MB-453 cells.
    Choi EJ; Kim GH
    Phytomedicine; 2008 Sep; 15(9):683-90. PubMed ID: 18541420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression.
    Halfter H; Friedrich M; Resch A; Kullmann M; Stögbauer F; Ringelstein EB; Hengst L
    Cancer Res; 2006 Jul; 66(13):6530-9. PubMed ID: 16818624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallic acid induces G2/M phase cell cycle arrest via regulating 14-3-3β release from Cdc25C and Chk2 activation in human bladder transitional carcinoma cells.
    Ou TT; Wang CJ; Lee YS; Wu CH; Lee HJ
    Mol Nutr Food Res; 2010 Dec; 54(12):1781-90. PubMed ID: 20564478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y; Buffolino P; Coppock DL
    Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vorinostat enhances protein stability of p27 and p21 through negative regulation of Skp2 and Cks1 in human breast cancer cells.
    Uehara N; Yoshizawa K; Tsubura A
    Oncol Rep; 2012 Jul; 28(1):105-10. PubMed ID: 22484732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
    Bhatt KV; Hu R; Spofford LS; Aplin AE
    Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
    Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
    Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression variation and significance of Skp2 and p27(kip1) during the proliferation of Jurkat cells].
    Lu JX; Wang YC; Shen AG; Zhao YM; Sun CL; Zhang DM; Cheng C
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):330-4. PubMed ID: 18953829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F; Giuliano AE; Law RE; Van Herle AJ
    Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells.
    Zi X; Grasso AW; Kung HJ; Agarwal R
    Cancer Res; 1998 May; 58(9):1920-9. PubMed ID: 9581834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydrotestosterone induces p27 degradation via direct binding with SKP2 in ovarian and breast cancer.
    Shi P; Zhang Y; Tong X; Yang Y; Shao Z
    Int J Mol Med; 2011 Jul; 28(1):109-14. PubMed ID: 21503567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.
    Choi EJ; Kim GH
    J Nutr Biochem; 2009 Apr; 20(4):285-90. PubMed ID: 18656338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
    Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK
    Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
    Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G
    Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells.
    Andreu EJ; Lledó E; Poch E; Ivorra C; Albero MP; Martínez-Climent JA; Montiel-Duarte C; Rifón J; Pérez-Calvo J; Arbona C; Prósper F; Pérez-Roger I
    Cancer Res; 2005 Apr; 65(8):3264-72. PubMed ID: 15833859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cadmium induces cell cycle arrest in rat kidney epithelial cells in G2/M phase.
    Xie J; Shaikh ZA
    Toxicology; 2006 Jul; 224(1-2):56-65. PubMed ID: 16730872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.